Signaling pathways involved in antioxidant control of glioma cell proliferation

Free Radical Biology and Medicine

Volumn 42, Issue 11, 2007, Pages 1715-1722

  Martín, Vanesa ^a   Herrera, Federico ^a   García Santos, Guillermo ^a,b   Antolín, Isaac ^a   Rodriguez Blanco, Jezabel ^a   Rodriguez, Carmen ^a,b  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

C6; Cell proliferation; Free radicals; Glioma; Reactive oxygen species; Signaling pathways

Indexed keywords

ACETYLCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN P21;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLIOMA CELL; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GLIOMA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; UP-REGULATION;

RATTUS;

EID: 34247244291     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.02.028     Document Type: Article

References (56)

1. Finkel T. Oxygen radicals and signalling. Curr. Opin. Cell Biol. 10 (1998) 248-253
2. Shackelford M., Yu Z.X., Ferrans V.J., Irani K., and Finkel T. Oxidative stress and cell cycle checkpoint. Free Radic. Mol. Med. 28 (2000) 1387-1404
3. Shibanuma M., Kuroki T., and Nose K. Induction of DNA replication and expression of proto-oncogenes c-myc and c-fos in quiescent Balb/3T3 cells by xanthine-xanthine oxidase. Oncogene 3 (1988) 14-21
4. DeHaan J.B., Cristiano F., Lanello R., Bladier C., Kelner M.J., and Kola I. Elevation in the ratio of Cu/Zn superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum. Mol. Genet. 5 (1996) 283-292
5. Allen R.G., and Balin A.K. Oxidative influence in development of differentiation: an overview of a free radical theory of development. Free Radic. Biol. Med. 6 (1989) 631-661
6. Hockenbery D.M., Oltvai Z.N., Yin Y.M., Milliman C.L., and Korsmeyer S.J. Bcl-2 function in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
7. Harman D. Free radical theory of aging. Mutat. Res. 275 (1992) 257-266
8. Johnston M.V., Trescher W.H., Ishida A., and Nakajima W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res. 49 (2001) 735-741
9. Klaunig J.E., and Kamendulis L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 239-267
10. Szatrowski T.P., and Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51 (1991) 794-798
11. Toyokuni S., Okamoto K., Yodoi J., and Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 358 (1995) 1-3
12. Kondo S., Toyokuni S., Iwasa Y., Tanaka T., Onodera H., Hiai H., and Imamura M. Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic. Biol. Med. 27 (1999) 401-410
13. Khan A.U., and Wilson T. Reactive oxygen species as cellular messengers. Chem. Biol. 2 (1995) 437-445
14. Menon S.G., Sarsour E.H., Spitz D.R., Higashikubo R., Sturm M., Zhang H., and Goswami P.C. Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res. 63 (2003) 2109-2117
15. Valko M., Rhodes C.J., Moncol J., Izakovic M., and Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160 (2006) 1-40
16. 2. Eur. J. Biochem. 267 (2000) 1933-1944
17. Dabrowski A., Boguslowicz C., Dabrowska M., Tribillo I., and Gabryelewicz A. Reactive oxygen species activate mitogen-activated protein kinases in pancreatic acinar cells. Pancreas 21 (2000) 376-384
18. Meyer M., Pahl H.L., and Baeuerle P.A. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem. Biol. Interact. 91 (1994) 91-100
19. Muller J.M., Rupec R.A., and Baeuerle P.A. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods 11 (1997) 301-312
20. Rameh L.E., and Cantley L.C. The role of phosphoinositide-3-kinase lipid products in cell function. J. Biol. Chem. 274 (1999) 8347-8350
21. Song G., Ouyang G., and Bao S. The activation of Akt/PKB signalling pathway and cell survival. J. Cell. Mol. Med. 9 (2005) 59-71
22. Kane L.P., Shapiro V.S., Stokoe D., and Weiss A. Induction of NF-κB by the Akt/PKB kinase. Curr. Biol. 9 (1999) 601-604
23. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2 (2004) 301-310
24. Li X., and Stark G.R. NFkappaB-dependent signaling pathways. Exp. Hematol. 30 (2002) 285-296
25. Haas-Kogan D., Shalev N., Wong M., Mills G., Yount G., and Stokoe D. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor MMAC/PTEN. Curr. Biol. 8 (1998) 1195-1198
26. Moriya S., Kazlauskas A., Akimoto K., Hirai S., Mizuno K., Takenawa T., Fukui Y., Watanabe Y., Ozaki S., and Ohno S. Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 151-155
27. Amin A.R., Ichigotani Y., Oo M.L., Biswas M.H., Yuan H., Huang P., Mon N.N., and Hamaguchi M. The PLC-PKC cascade is required for IL1-beta-dependent ERK and Akt activation: their role in proliferation. Int. J. Oncol. 23 (2003) 1727-1731
28. Aeder S.E., Martin P.M., Soh J.W., and Hussaini I.M. PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. Oncogene 23 (2004) 9062-9069
29. Bredel M., and Pollack I.F. The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy. Acta Neurochir. (Wien) 139 (1997) 1000-1001
30. Sharif T.R., and Sharif M. Overexpression of protein kinase C epsilon in astroglial brain tumor-derived cell lines and primary tumor samples. Int. J. Oncol. 15 (1999) 237-244
31. Gopalakrishna R., and Jaken S. Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 28 (2000) 1346-1349
32. Gopalakrishna R., and Gundimeda U. Antioxidant regulation of protein kinase C in cancer prevention. J. Nutr. 132 (2002) 3819S-3823S
33. Slaga T.J. Inhibition of the induction of cancer by antioxidants. Adv. Exp. Med. Biol. 369 (1995) 167-174
34. Ambrosone C.B. Oxidants and antioxidants in breast cancer. Antioxid. Redox Signaling 2 (2000) 903-917
35. Shekelle P., Hardy M.L., Coulter I., Udani J., Spar M., Oda K., Jungvig L.K., Tu W., Suttorp M.J., Valentine D., Ramirez L., Shanman R., and Newberry S.J. Effect of the supplemental use of antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cancer. Evid. Rep. Technol. Assess. (Summ.) 75 (2003) 1-3
36. DeFlora S., Cesarone C.F., Balansky R.M., Albini A., D'Agostini F., Bennicelli C., Bagnasco M., Camoirano A., Scatonili L., Rovida A., and Izzotti A. Chemopreventive properties and mechanism of N-acetylcysteine: the experimental background. J. Cell. Biochem. 58 (1995) 33-41
37. DeFlora S., Balansky R.M., Bennicelli C., Camoirano A., D'Agostini F., Izzotti A., and Cesarone C.F. Mechanism of anticarcinogenesis: the example of N-acetylcysteine. In: Ioannides C., and Lewis D.F.V. (Eds). Drugs, diet and disease. Mechanism approaches to cancer vol. 1 (1995), Ellis Horwood, Hemel Hempstead, UK 151-203
38. Bass D.A., Parce J.W., Dechatelet L.R., Szjda P., Seeds M.C., and Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a grade response to membrane stimulation. J. Immunol. 130 (1983) 1910-1917
39. Dignam J.D., Levobitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
40. Floreani M., Skaper S.D., Facci L., Lipartiti M., and Giusti P. Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues. FASEB J. 11 (1997) 1309-1315
41. Kapoor G.S., and O'Rourke D.M. Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches. Cancer Biol. Ther. 2 (2003) 22-34
42. Martin V., Herrera F., Carrera-Gonzalez P., Garcia-Santos G., Antolin I., Rodríguez-Blanco J., and Rodríguez C. Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res. 66 (2006) 1081-1088
43. Gupta S., Afaq F., and Mukhtar H. Involvement of nuclear factor-kappa B, bax and bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene 21 (2002) 3727-3738
44. Irani K., Xia Y., Zweier J.L., Sollot S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., and Goldschmidt-Clermont P.J. Mitogenic signalling mediated by oxidants in Ras-transformed fibroblasts. Science 275 (1997) 1649-1652
45. Benhar M., Dalyot I., Engelberg D., and Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell. Biol. 21 (2001) 6913-6926
46. Chinery R., Beauchamp R.D., Shyr Y., Kirkland S.C., Coffey R.J., and Morrow J.D. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res. 58 (1998) 2323-2327
47. Storz P. Reactive oxygen species in tumor progression. Front. Biosci. 10 (2005) 1881-1896
48. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., and Stanbridge E. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
49. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
50. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., and Hu L.S. Akt promotes cell survival by phosphorylating and inhibiting Forkhead transcription factor. Cell 96 (1999) 856-857
51. Lin A., and Karin M. NF-κB in cancer: a marked target. Semin. Cancer Biol. 13 (2003) 107-114
52. Wang H., Wang H., Zhang W., Huang H.J., Liao W.S., and Fuller G.N. Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab. Invest. 84 (2004) 941-951
53. Mabuchi S., Ohmichi M., Nishio Y., Hayasaka T., Kimura A., Ohta T., Saito M., Kawagoe J., Takahashi K., Yada-Hashimoto N., Sakata M., Motoyama T., Kurachi H., Tasaka K., and Murata Y. Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J. Biol. Chem. 279 (2004) 23477-23485
54. El Bekay R., Alvarez M., Monteseirin J., Alba G., Chacon P., Vega A., Martin-Nieto J., Jimenez J., Pintado E., Bedoya F.J., and Sobrino F. Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB. Blood 102 (2003) 662-671
55. Storz P., Doppler H., and Toker A. Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor kappaB. Mol. Pharmacol. 66 (2004) 870-879
56. Shukla S., and Gupta S. Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells. Mol. Carcinog. 39 (2004) 114-126